Becton Dickinson & Co. (BDX) kicked off at the price of $233.87: Venture capitalists have an exciting new opportunity

Becton Dickinson & Co. (NYSE: BDX) kicked off on Tuesday, down -0.86% from the previous trading day, before settling in for the closing price of $235.91. Over the past 52 weeks, BDX has traded in a range of $224.00-$287.32.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 4.18%. While this was happening, its average annual earnings per share was recorded 6.88%. With a float of $288.61 million, this company’s outstanding shares have now reached $290.39 million.

Let’s determine the extent of company efficiency that accounts for 73000 employees.

Becton Dickinson & Co. (BDX) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Becton Dickinson & Co. is 0.14%, while institutional ownership is 87.68%. The most recent insider transaction that took place on Jun 10 ’24, was worth 71,793. In this transaction SVP,Controller&Chief Acct Off of this company sold 300 shares at a rate of $239.31, taking the stock ownership to the 1,976 shares. Before that another transaction happened on May 15 ’24, when Company’s EVP and President EMEA sold 3,300 for $236.73, making the entire transaction worth $781,224. This insider now owns 11,308 shares in total.

Becton Dickinson & Co. (BDX) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 6.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.60% during the next five years compared to 52.43% growth over the previous five years of trading.

Becton Dickinson & Co. (NYSE: BDX) Trading Performance Indicators

Take a look at Becton Dickinson & Co.’s (BDX) current performance indicators. Last quarter, stock had a quick ratio of 0.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.43. Likewise, its price to free cash flow for the trailing twelve months is 22.34.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.54, a number that is poised to hit 3.31 in the next quarter and is forecasted to reach 14.28 in one year’s time.

Technical Analysis of Becton Dickinson & Co. (BDX)

Looking closely at Becton Dickinson & Co. (NYSE: BDX), its last 5-days average volume was 1.33 million, which is a drop from its year-to-date volume of 1.44 million. As of the previous 9 days, the stock’s Stochastic %D was 63.17%. Additionally, its Average True Range was 3.96.

During the past 100 days, Becton Dickinson & Co.’s (BDX) raw stochastic average was set at 40.42%, which indicates a significant increase from 32.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.25% in the past 14 days, which was lower than the 18.09% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $234.48, while its 200-day Moving Average is $242.52. However, in the short run, Becton Dickinson & Co.’s stock first resistance to watch stands at $235.19. Second resistance stands at $236.52. The third major resistance level sits at $237.52. If the price goes on to break the first support level at $232.86, it is likely to go to the next support level at $231.86. Now, if the price goes above the second support level, the third support stands at $230.53.

Becton Dickinson & Co. (NYSE: BDX) Key Stats

The company with the Market Capitalisation of 67.59 billion has total of 289,006K Shares Outstanding. Its annual sales at the moment are 19,372 M in contrast with the sum of 1,484 M annual income. Company’s last quarter sales were recorded 5,045 M and last quarter income was 537,000 K.